Dr. Andrew W. Pippas
Claim this profileJohn B Amos Cancer Center
Studies Breast Cancer
Studies Breast cancer
18 reported clinical trials
52 drugs studied
Area of expertise
1Breast Cancer
Stage III
Stage IV
Stage I
2Breast Cancer
Stage I
Stage II
PD-L1 positive
Affiliated Hospitals
Clinical Trials Andrew W. Pippas is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Ivaltinostat + Capecitabine
for Pancreatic Cancer
This trial tests ivaltinostat with capecitabine in patients with advanced pancreatic cancer who have not worsened after initial treatment. The goal is to find a safe and effective dose and to see if this combination can better control the cancer. Capecitabine is a medication that is converted into another drug in the body, showing better selectivity and tolerability in tumor tissues.
Recruiting3 awards Phase 1 & 211 criteria
More about Andrew W. Pippas
Clinical Trial Related8 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Andrew W. Pippas has experience with
- Pembrolizumab
- Prednisone
- Repotrectinib (TPX-0005)
- EndoPredict®
- Ladiratuzumab Vedotin
- Nanosomal Docetaxel Lipid Suspension
Breakdown of trials Andrew W. Pippas has run
Breast Cancer
Breast cancer
Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew W. Pippas specialize in?
Andrew W. Pippas focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage III patients, or patients who are Stage IV.
Is Andrew W. Pippas currently recruiting for clinical trials?
Yes, Andrew W. Pippas is currently recruiting for 6 clinical trials in Columbus Georgia. If you're interested in participating, you should apply.
Are there any treatments that Andrew W. Pippas has studied deeply?
Yes, Andrew W. Pippas has studied treatments such as Pembrolizumab, Prednisone, Repotrectinib (TPX-0005).
What is the best way to schedule an appointment with Andrew W. Pippas?
Apply for one of the trials that Andrew W. Pippas is conducting.
What is the office address of Andrew W. Pippas?
The office of Andrew W. Pippas is located at: John B Amos Cancer Center, Columbus, Georgia 31904 United States. This is the address for their practice at the John B Amos Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.